Tag: pfizer

Pfizer refused to supply South America with covid vaccines until governments removed all liability for injuries, deaths

As a condition of supplying Wuhan coronavirus (Covid-19) jabs to Columbia, Big Pharma giants Pfizer-BioNTech and AstraZeneca reportedly struck a secret immunity deal with the nation’s government, which agreed to indemnify the multinational corporations from liability for injuries and deaths caused by the injections.

Columbian officials “accidentally” published contracts from Pfizer-BioNTech and AstraZeneca showing that the 25 million doses of Fauci Flu shots that were recently shipped to the country would not have come were it not for the pharma giants first being awarded total immunity.

While attempting to send the confidential information to a regional court following a tutelage filing, Columbia’s Council of State, which is considered the supreme judicial authority in the country, mistakenly disclosed the contracts signed between the Columbian government and the pharmaceutical behemoths.

The alleged mistake was quickly discovered by the government and the documents were removed, but not before the Columbian nonprofit “Anticorruption Institute” accessed and copied it, later leaking it in order “to defend transparency and in a bid to safeguard the fundamental right of access to public information.”

Keep reading

Pfizer sells $7.8 billion in Covid shots in the second quarter, raises 2021 guidance on vaccine sales

Pfizer said Wednesday it sold $7.8 billion in Covid-19 shots in the second quarter and raised its 2021 sales forecast for the vaccine to $33.5 billion from $26 billion, as the delta variant spreads and scientists debate whether people will need booster shots.

The company’s second-quarter financial results also beat Wall Street expectations on earnings and revenue. Here’s how Pfizer did compared with what Wall Street expected, according to average estimates compiled by Refinitiv:

  • Adjusted earnings per share: $1.07 per share vs. 97 cents per share expected
  • Revenue: $18.98 billion vs. $18.74 billion forecast

Pfizer expects an adjusted pretax profit in the high 20% range of revenue for the vaccine.

The company now expects full-year earnings in the range of $3.95 to $4.05 per share. That’s up from its prior range of $3.55 to $3.65 per share. It expects revenue in the range of $78 billion to $80 billion, up from its previous estimate of $70.5 billion to $72.5 billion.

Keep reading

Heart inflammation cases in young men higher than expected after mRNA vaccines -U.S. CDC

Preliminary findings from two vaccine safety monitoring systems suggest a higher-than-expected number of cases of heart inflammation after the second dose of mRNA COVID-19 vaccines in young men, the U.S. Centers for Disease Control and Prevention (CDC) said on Thursday.

More than half of the myocarditis or pericarditis cases reported to the U.S. Vaccine Adverse Event Reporting System after patients had received either the Pfizer/BioNTech or Moderna vaccines were in people between the ages of 12 and 24, the CDC said. Those age groups accounted for less that 9% of the doses administered.

“We clearly have an imbalance there,” Dr. Tom Shimabukuro, deputy director of the CDC’s Immunization Safety Office, said in a presentation here to an advisory committee to the U.S. Food and Drug Administration that is meeting on Thursday.

He said that the Vaccine Safety Datalink (VSD) – another safety monitoring system – showed an increased incidence of the heart inflammation in 16 to 39 year olds after their second dose of the shots when compared to the rate observed after their first dose.

Keep reading

FDA Document Reveals 86% of Children Who Participated in Pfizer COVID Vaccine Trial Experienced Adverse Reactions

A publicly available FDA “fact sheet” document reveals that 86% of children who participated in a Pfizer covid vaccine trial reported adverse reactions ranging from “mild” to “serious.”

As part of the vaccine experiments, children aged 12 to 15 are being injected with mRNA sequences that take control of their cells, causing them to churn our spike proteins in their blood. Spike proteins cause vascular disease and blood clots. Even the Jonas Salk Institute conclusively identifies spike proteins as the culprit behind vascular disease and blood clots.

This is all openly admitted by the FDA, which has published extremely disturbing reports of adverse reactions experienced by children in a Pfizer covid vaccine “fact sheet” labeled 144413. See the original FDA document here (PDF).

In case the FDA removes this sheet, we have archived it at Natural News servers here (PDF).

Keep reading

COVID-19: Israel finds possible link between vaccine, myocarditis cases

About one in 100,000 people who received the Pfizer coronavirus vaccine suffered from myocarditis – an inflammation of the heart muscle – a preliminary report redacted by the committee of experts tasked by the Health Ministry to monitor the inoculation’s side effect has found, Channel 12 reported on Friday.The researchers also stressed that more research is needed to confirm the connection between the vaccine and the phenomena.The leaked document showed that most cases were reported among young men aged 18-30. A total of 62 cases of myocarditis have occurred so far in Israel around the time of the vaccination, 56 of them after the second dose. Some 55 cases occurred among men.

Keep reading

According To ALARMING New Report: Pfizer And Moderna COVID Vaccines Could Easily Trigger Alzheimer’s, ALS, And Other Neurological Degenerative Diseases

As we already reported a few days ago, over 60% of the new COVID cases involve people who have already been vaccinated.

And now, an alarming new report in Microbiology and Infectious Disease reveals the mRNA vaccines could easily trigger Alzheimer’s disease, ALS, and other neurological and cognitive degenerative diseases.

From the report of J. Bart Classen, MD:

Development of new vaccine technology has been plagued with problems in the past. The current RNA based SARS- CoV-2 vaccines were approved in the US using an emergency order without extensive long term safety testing.

Dr. Classen and his colleagues discovered that the vaccine increases the likelihood of these hideous diseases by opening a pathway into human DNA, which is exactly what this gene-therapy drug is intended to do:

The results indicate that the vaccine RNA has specific sequences that may induce TDP-43 and FUS to fold into their pathologic prion confirmations. In the current analysis a total of sixteen UG tandem repeats (ΨGΨG) were identified and additional UG (ΨG) rich sequences were identified.

Two GGΨA sequences were found. Potential G Quadruplex sequences are possibly present but a more sophisticated computer program is needed to verify these. Furthermore, the spike protein, created by the translation of the vaccine RNA, binds angiotensin converting enzyme 2 (ACE2), a zinc containing enzyme.

More about that issue with zinc:

This interaction has the potential to increase intracellular zinc. Zinc ions have been shown to cause the transformation of TDP-43 to its pathologic prion configuration. The folding of TDP-43 and FUS into their pathologic prion confirmations is known to cause ALS, front temporal lobar degeneration, Alzheimer’s disease and other neurological degenerative diseases.

Dr. Classen’s ALARMING conclusion:

The enclosed finding as well as additional potential risks leads the author to believe that regulatory approval of the RNA based vaccines for SARS-CoV-2 was premature and that the vaccine may cause much more harm than benefit.

Click HERE if you want to read the full report of J. Bart Classen, MD.

Keep reading

Pfizer CEO’s Israel visit canceled because he is not fully vaccinated

Pfizer CEO Albert Bourla has canceled his expected visit to Israel after it turned out he has not been fully vaccinated against the coronavirus, N12 reported Friday.According to the channel, Bourla, as well as members of the delegation that was meant to accompany him during his visit, have not received the second dose of the vaccine.As a result, it was decided to delay the visit by several days, which also posed a logistic challenge because of the upcoming Israeli elections. Bourla said in December that he has not yet received the vaccine yet because he does not want to “cut in line,” and would wait until his age group is next in line for getting vaccinated. As such, he has received the first dose, but not the second one yet. Pfizer did not respond to The Jerusalem Post‘s request for comment.

Keep reading